Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI
Pediatric News ,
In the placebo-controlled REDUCE-IT trial, icosapent ethyl (IPE) was linked to a significant reduction in major adverse…
Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI
Pediatric News ,
In the placebo-controlled REDUCE-IT trial, icosapent ethyl (IPE) was linked to a significant reduction in major adverse…
Vascepa's CV Mortality Benefit Magnified in MI Patients
Medscape,
In the placebo-controlled REDUCE-IT trial, icosapent ethyl (IPE) was linked to a significant reduction in major adverse…
Icosapent ethyl’s CV mortality benefit magnified in patients with prior MI
Pediatric News ,
In the placebo-controlled REDUCE-IT trial, icosapent ethyl (IPE) was linked to a significant reduction in major adverse…